trientine has been researched along with Liver Diseases in 6 studies
Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " He was treated with trientine for more than 10 years and suffered from anemia and liver dysfunction." | 3.77 | Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction. ( Abe, S; Harada, M; Harada, R; Hiura, M; Honma, Y; Matsuhashi, T; Miyagawa, K; Shibata, M; Tabaru, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, M | 1 |
| Miyagawa, K | 1 |
| Honma, Y | 1 |
| Hiura, M | 1 |
| Shibata, M | 1 |
| Matsuhashi, T | 1 |
| Abe, S | 1 |
| Harada, R | 1 |
| Tabaru, A | 1 |
| Hayashi, H | 1 |
| Shinohara, T | 1 |
| Goto, K | 1 |
| Fujita, Y | 1 |
| Murakami, Y | 1 |
| Hattori, A | 1 |
| Tatsumi, Y | 1 |
| Shimizu, A | 1 |
| Ichiki, T | 1 |
| Leinweber, B | 1 |
| Möller, JC | 1 |
| Scherag, A | 1 |
| Reuner, U | 1 |
| Günther, P | 1 |
| Lang, CJ | 1 |
| Schmidt, HH | 1 |
| Schrader, C | 1 |
| Bandmann, O | 1 |
| Czlonkowska, A | 1 |
| Oertel, WH | 1 |
| Hefter, H | 1 |
| Ede, RJ | 1 |
| Mowat, AP | 1 |
| Ishiyama, H | 1 |
| Ogino, K | 1 |
| Hobara, T | 1 |
| Shimomura, Y | 1 |
| Kanbe, Y | 1 |
| Yamashita, S | 1 |
| Twedt, DC | 1 |
| Hunsaker, HA | 1 |
| Allen, KG | 1 |
6 other studies available for trientine and Liver Diseases
| Article | Year |
|---|---|
Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction.
Topics: Adult; Anemia; Ceruloplasmin; Chelating Agents; Chelation Therapy; Copper; Hemochromatosis; Hepatole | 2011 |
Liver structures of a patient with idiopathic copper toxicosis.
Topics: Ascites; Chelating Agents; Child; Copper; Diagnosis, Differential; Hepatocytes; Humans; Liver; Liver | 2012 |
Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
Topics: Adult; Age of Onset; Antirheumatic Agents; Chelating Agents; Drug Therapy, Combination; Female; Germ | 2008 |
Wilson's disease: a 1984 perspective.
Topics: Adolescent; Adult; Bone and Bones; Ceruloplasmin; Child; Child, Preschool; Copper; Diagnosis, Differ | 1984 |
The copper chelating agent tetraethylenepentamine inhibits copper, zinc-superoxide dismutase activity in rat liver: a possible mechanism for its hepatotoxicity.
Topics: Alanine Transaminase; Animals; Chelating Agents; Chemical and Drug Induced Liver Injury; Drug Admini | 1991 |
Use of 2,3,2-tetramine as a hepatic copper chelating agent for treatment of copper hepatotoxicosis in Bedlington terriers.
Topics: Animals; Copper; Dog Diseases; Dogs; Ethylenediamines; Female; Iron; Liver; Liver Diseases; Male; Me | 1988 |